Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...

Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global ...

Cystic fibrosis is typically screened for in the newborn ... because your baby would have other symptoms, such as sudden, ...

The FDA has approved Novartis Coartem Baby, the first malaria treatment designed for newborns and young infants. The medicine, developed in collaboration with Medicines for Malaria Venture, a ...

Several African countries where malaria is widespread are expected to swiftly approve the new medicine following Swissmedic’s ...